Unione Europea - slovacco - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.

Slovacchia - slovacco - myHealthbox

bayer ag - emulgovateľný koncentrát - bixafen 50 g/l; prothioconazole 100 g/l; spiroxamin 250 g/l

Slovacchia - slovacco - myHealthbox

bayer ag - emulgovateľný koncentrát - bixafen 50 g/l; prothioconazole 100 g/l; spiroxamin 250 g/l

Unione Europea - slovacco - EMA (European Medicines Agency)

novo nordisk a/s - eptakog alfa (aktivovaný) - hemophilia b; thrombasthenia; factor vii deficiency; hemophilia a - antihemoragiká - novoseven je indikovaný na liečbu krvácania epizódy a na prevenciu krvácania u tých, podstupujúcich chirurgický zákrok alebo invazívne postupy v týchto skupín pacientov:u pacientov s vrodenými haemophilia s inhibítory na koagulačných faktorov viii alebo ix > 5 bethesda jednotiek (bu);u pacientov s vrodenými haemophilia, ktorí sa očakáva, že majú vysoký anamnestic odpovede na faktor viii alebo faktor ix správy;u pacientov s získané haemophilia;u pacientov s vrodenými faktor vii nedostatkov;u pacientov s glanzmann je thrombasthenia s protilátok a krvných doštičiek glykoproteín (gp) iib-iiia a / alebo human leucocyte antigénmi (hla), a s minulosti, alebo súčasnosti refractoriness na doštičiek transfúzie. u pacientov s glanzmann je thrombasthenia s minulosti, alebo súčasnosti refractoriness na doštičiek transfúzie, alebo krvných doštičiek, kde nie sú k dispozícii.

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sanofi-aventis slovakia s.r.o., slovensko - iné liečivá podporujúce tvorbu jaziev - 46 - dermatologica

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva, k.s., Česká republika - kodeín, kombinácie okrem psycholeptík - 07 - analgetica, antipyretica

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glaxosmithkline (ireland) limited, Írsko - salbutamol - 14 - bronchodilatantia, antiasthmatica

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

wörwag pharma gmbh & co. kg, nemecko - kyselina tioktová - 87 - varia i

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

opella healthcare slovakia s.r.o., slovensko - ibuprofen - 29 - antirheumatica, antiphlogistica, antiuratica

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fagron a.s., Česká republika - peroxid vodíka - 32 - antiseptica, desinficientia (lokÁlne)